articles

Median survival for a person with aggressive glioblastoma is 14.6 months, according to the American Brain Tumor Association. Approximately 30 percent of patients survive for 2 years, and a 2009 study suggested 10 percent... More »

Although prognosis varies for each patient, the majority of patients diagnosed with stage 4 glioblastoma live for less than a year, according to Cancer.net. Approximately six percent of patients with stage 4 glioblastoma... More »

Brain tumors rarely metastasize to other organs. However, if a cancerous tumor spreads to other parts of the brain or spinal cord, the patient's prognosis is poorer than when the tumor is localized, explains the National... More »

www.reference.com Health Conditions & Diseases Cancer
similar articles

The average life expectancy for a patient diagnosed with gliobastoma multiforme is three months, according to Medscape. With aggressive treatment, including chemotherapy, surgical resection and radiation therapy, life ex... More »

www.reference.com Health Conditions & Diseases Cancer

Life expectancy statistics for glioblastoma depend on the age of the patient, the type of treatment and the aggressiveness of the cancer, explains the American Brain Tumor Association. Generally, less than 10 percent of ... More »

www.reference.com Health Conditions & Diseases Cancer

The American Brain Tumor Association indicates that the average life expectancy for adults who receive standard treatment for giloblastoma is between two and three years. For adults diagnosed with more aggressive gilobla... More »

Adults who are diagnosed with glioblastoma multiforme have a median survival of 14.6 months, as of 2015; only 30 percent of patients survive for two years after diagnosis, according to the American Brain Tumor Associatio... More »

www.reference.com Health Conditions & Diseases Cancer